IDEX (IEX) Beat Estimates And Landed Record Orders, Is It Still Below Fair Value?

IDEX (IEX) reported strong Q2 earnings, record orders over $1B, and a 42.07% total shareholder return over the past year. Analysts' consensus price target is $254.50, with some valuing it higher at $280.0 and others lower at $215.0. Investors should monitor tariff pressures and sector demand.

Original reporting
Published Aug 30, 2026, 7:37 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 30, 2026, 2:08 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
IDEX (IEX) Beat Estimates And Landed Record Orders, Is It Still Below Fair Value? — source image
Decision brief

The 30-second read

$IEXBullishLow
01

Why it matters

The article reiterates known earnings results, offering limited new insight for traders.

02

Market read

Reaffirms IDEX's recent performance but adds little new information; relevance to traders is low.

03

What to watch

Potential supply‑chain constraints and competitive pressure from larger rivals may limit upside.

Relevance 4/10Novelty 2/10Timing: post‑Q2 earnings

Background

Commentary on IDEX's Q2 earnings beat, record order book, and recent director resignation.

Company-level read

Ticker impact

$IEXBullishMedium confidence
Context

IDEX reported a Q2 earnings beat and secured >$1B of new orders, fueling recent stock momentum.

Expected impact

Potential upside toward $250 if momentum sustains.

Evidence & confidence

Earnings beat and order backlog are favorable, but valuation concerns and tariff risks temper the outlook.

Market effects

Industrial equipment sector may benefit from demonstrated demand resilience.

U.S. industrial stocks could see modest support from IDEX's order growth.

Limited; primarily affects U.S. industrial equities.

Counterpoint

Tariff‑driven cost pressures and weakening demand in semiconductors or agriculture could offset order gains.

Key entities

  • IDEX Corporation

    Industrial equipment maker reporting Q2 beat and >$1B orders.

Related articles

$IEXHighAI 8/10

DA Davidson raises IDEX stock price target to $245 on strength

DA Davidson raised its price target on IDEX Corp (NYSE:IEX) to $245 from $240, citing strength in its Health & Science Technologies and Fire & Safety segments. The stock has risen 39% over the past year. IDEX reported Q3 2026 earnings of $2.33 per share, beating estimates, with revenue of $952 million. The company also raised its full-year guidance.

$IEXMedAI 8/10

Idex: Q3 Earnings Snapshot

IDEX Corp. (IEX) reported Q3 net income of $144.1M, or $1.95 per share, exceeding analyst estimates. Adjusted EPS was $2.33. Revenue was $951.7M, also beating forecasts. The company raised its full-year EPS guidance to $8.91-$8.96 per share.

$IEXHighAI 8/10

IDEX (IEX) Q3 2026 Earnings Call Transcript

IDEX (IEX) reported Q3 2026 net sales of $952M, up 8%, and adjusted EPS of $2.33, up 15%. Organic orders reached $991M, growing 13%. HST, FMT, and FSDP segments showed growth. Full-year guidance raised: organic growth 6.5-6.8%, adjusted EPS $8.91-$8.96. Inflation and chemical sector weakness noted as risks.

$IEXHighAI 8/10

IDEX Q3 2026 slides: advantaged markets drive beat, guidance raised

IDEX Corporation (NYSE:IEX) reported Q3 2026 earnings with 8% organic sales growth and 15% increase in adjusted EPS, driven by 'advantaged markets'. Sales reached $952M, adjusted EBITDA margin expanded to 27.8%, and free cash flow grew 14%. The company raised its full-year outlook, with shares up 0.92% to $235.35. HST segment led growth with 13% organic sales growth.

$IEXMedAI 8/10

IDEX (NYSE:IEX) beats Q3 2026 sales expectations

IDEX reported Q3 2026 revenue of $951.7 million, beating estimates by 1.8%. Adjusted EPS was $2.33, a 4% beat. Adjusted EBITDA reached $264.8 million, a 3.2% beat. Management raised full-year adjusted EPS guidance to $8.94. Operating margin remained steady at 21.9%, while free cash flow margin improved to 22.5%.